METHIMAZOLE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for methimazole and what is the scope of patent protection?

Methimazole is the generic ingredient in two branded drugs marketed by Bionpharma, Chartwell Rx, Discovery Therap, Heritage Pharma, Macleods Pharms Ltd, Mylan, Qingdao Baheal Pharm, Rising, Sun Pharm Inds Inc, King Pharms, and King Pharms Llc, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for methimazole. Fifteen suppliers are listed for this compound.

Summary for METHIMAZOLE

US Patents:	0
Tradenames:	2
Applicants:	11
NDAs:	11
Drug Master File Entries:	3
Finished Product Suppliers / Packagers:	15
Raw Ingredient (Bulk) Api Vendors:	174
Clinical Trials:	22
Patent Applications:	5,310
Drug Prices:	Drug price trends for METHIMAZOLE
Drug Sales Revenues:	Drug sales revenues for METHIMAZOLE
What excipients (inactive ingredients) are in METHIMAZOLE?	METHIMAZOLE excipients list
DailyMed Link:	METHIMAZOLE at DailyMed

See drug prices for METHIMAZOLE

Drug Sales Revenue Trends for METHIMAZOLE

See drug sales revenues for METHIMAZOLE

Recent Clinical Trials for METHIMAZOLE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Case Comprehensive Cancer Center	Phase 2
The First Affiliated Hospital of Xiamen University	Phase 2/Phase 3
Jiangsu Province Hospital with Integration of Chinese and Western Medicine	Early Phase 1

See all METHIMAZOLE clinical trials

Pharmacology for METHIMAZOLE

Drug Class	Thyroid Hormone Synthesis Inhibitor
Mechanism of Action	Thyroid Hormone Synthesis Inhibitors

Medical Subject Heading (MeSH) Categories for METHIMAZOLE

Antithyroid Agents

US Patents and Regulatory Information for METHIMAZOLE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Qingdao Baheal Pharm	METHIMAZOLE	methimazole	TABLET;ORAL	040547-001	Feb 18, 2005	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
King Pharms Llc	TAPAZOLE	methimazole	TABLET;ORAL	040320-002	Mar 31, 2000		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mylan	METHIMAZOLE	methimazole	TABLET;ORAL	040350-003	Jun 7, 2001		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.